2014-02-20 18:26:08 - Two-Day Event to Include Sessions Covering Litigation Trends, FCPA and Anti-Corruption Infringements, and Avoiding Anti-Trust Scrutiny
(Chicago, IL) – The inaugural Pharmaceutical and Medical Device Legal and Compliance Forum is scheduled to take place March 24-25, 2014 in Alexandria, Virginia, offering regulatory and legal professionals an opportunity to discuss the current events and challenges within the healthcare industry with some of the biggest names in the field.
Topics for discussion at the forum include leveraging digital and mobile networks to increase consumer interaction, the FDA’s proposed generic labeling revisions, and effective litigation crisis management strategies to mitigate damage to public image. The conference, hosted by Q1 Productions, will provide attendees with several networking opportunities and a plethora of panel discussions and sessions led by more than two dozen distinguished presenters such as Kasper Stofelmayr of Bayer
Corporation and Rebecca Wood of Sidley Austin.
Participants will have the unique opportunity to partake in a panel discussion with representatives from the Department of Justice, Federal Trade Commission and the Food and Drug Administration regarding the projected government enforcement and litigation trends for 2014. With a variety of interactive breakout sessions and topics on the agenda, attendees will be given more opportunities for networking and education.
For more information or to register for the Pharmaceutical and Medical Device Legal and Compliance Forum, or any other Q1 Productions events, please visit www.q1productions.com/legalforum
Follow us: @Q1Productions #q1legal
About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.